Patients with PAH should undergo careful evaluation for PVOD. Recognition of characteristic clinical, radiological, and genetic features enables suspicion of this rare PAH subtype and guides cautious titration of targeted therapies. Lung transplantation remains the preferred treatment option for PVOD patients.
Radchenko et al. (Wed,) studied this question.